CVS vs NVS
CVS: CVS Health is an integrated health care giant combining extensive retail pharmacy networks, pharmacy benefits management, and comprehensive health insurance offerings to simplify consumer health experiences. NVS: Global pharmaceutical and biotechnology company pioneering disease-modifying treatments across oncology, immunology, neuroscience, and rare genetic diseases.
Side-by-side fundamentals
| Metric | CVS | NVS | Edge |
|---|---|---|---|
| Price as of 2026-07-31 close | $104.43 | $156.11 | |
| Market cap as of 2026-08-03 | $133.2B | $232.1B | |
| P/E as of 2026-08-03 | 46.19 | 22.53 | NVS lower |
| PEG as of 2026-08-03 | 3.30 | 3.66 | CVS lower |
| Net margin as of 2026-08-03 | +0.7% | +22.5% | NVS higher |
| Gross margin as of 2026-08-03 | +13.9% | +75.0% | NVS higher |
| Operating margin as of 2026-08-03 | +1.6% | +29.9% | NVS higher |
| ROE as of 2026-08-03 | +3.9% | +29.9% | NVS higher |
| ROA as of 2026-08-03 | +1.1% | +11.1% | NVS higher |
| Debt / equity as of 2026-08-03 | 0.81 | 1.18 | CVS lower |
| Revenue growth (YoY) as of 2026-08-03 | +7.6% | +3.3% | CVS higher |
| Revenue CAGR (3y) SEC XBRL | +7.6% | n/a | |
| Dividend yield as of 2026-08-03 | +2.5% | +2.9% | NVS higher |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-03 | 0.30 | 1.17 | |
| 1-year return as of 2026-07-31 close | +68.2% | +32.6% | CVS higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-31.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.